Pfizer to launch new Lipitor consumer effort

Share this article:
Pfizer told the Associated Press it plans to launch a new consumer ad campaign for its blockbuster cholesterol drug Lipitor during the first week of April. The campaign comprised of TV and print spots, will continue to feature Dr. Robert Jarvik, inventor of the artificial heart, but will add information about new uses for the drug, Walt Johnston, senior director and group leader for Lipitor marketing said. Earlier this month, Pfizer announced that the FDA approved Lipitor to reduce the risk of several serious problems in patients with heart disease, including hospitalizations for heart failure. A Pfizer spokesperson was not available at press time to provide additional details.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...